[Federal Register Volume 61, Number 127 (Monday, July 1, 1996)]
[Notices]
[Page 33938]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-16719]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Allergy and Infectious Diseases Special Emphasis 
Panel (SEP) meeting:

    Name of SEP: Master Agreement for HIV Preclinical Vaccine 
Development Category B: Evaluation of AIDS Vaccines in Non-Human 
Primates (Telephone Conference Call).
    Date: July 3, 1996.
    Time: 12:00 p.m.
    Place: Telephone Conference Call, 6003 Executive Blvd., Solar 
Bldg., Room 4C03, Bethesda, MD 20892-7610, (301) 402-4596.
    Contact Person: Dr. Christopher E. Beisel, Scientific Review 
Adm., 6003 Executive Boulevard, Solar Bldg., Room 4C03, Bethesda, MD 
20892-7610, (301) 402-4596.
    Purpose/Agenda: To evaluate contract proposals.

    The meeting will be closed in accordance with the provisions set 
forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.
(Catalog of Federal Domestic Assistance Programs Nos. 93.855, 
Immunology, Allergic and Immunologic Diseases Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health)

    Dated: June 24, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-16719 Filed 6-28-96; 8:45 am]
BILLING CODE 4140-01-M